Ikena Oncology Inc reports results for the quarter ended in March - Earnings Summary

ImageneBio

12/05/2022 19:00

* Ikena Oncology Inc  IKNA.OQ  reported a quarterly adjusted
loss
of 47 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 42 cents per share.
    * Revenue fell 2.6% to $3.38 million from a year ago; 
analysts
expected $4.57 million. 
    * Ikena Oncology Inc's reported EPS for the quarter was a
loss
of 47 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.1%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Ikena Oncology Inc shares had fallen by 38.0% this
quarter and
lost 69.9% so far this year.
    * The company reported a quarterly loss of $16.84 million.
    * Wall Street's median 12-month price target for Ikena
Oncology
Inc is $26.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 05:59 p.m.  ​All
figures in US dollars unless otherwise stated